Plasmodium falciparum: Differing effects of non-esterified fatty acids and phospholipids on intraerythrocytic growth in serum-free medium

Experimental Parasitology

Volumn 127, Issue 3, 2011, Pages 708-713

  Asahi, Hiroko ^a   Izumiyama, Shinji ^a   Tolba, Mohammed Essa Marghany ^a,b   Kwansa Bentum, Bethel ^a,c  

^a NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

Intraerythrocytic growth; Non esterified fatty acid; Phospholipids; Plasmodium falciparum; Serum free medium

Indexed keywords

BOVINE SERUM ALBUMIN; FATTY ACID; MYRISTIC ACID; OLEIC ACID; PALMITIC ACID; PHOSPHOLIPID; STEARIC ACID;

ARTICLE; CARBOHYDRATE ANALYSIS; CONTROLLED STUDY; CULTURE MEDIUM; DEVELOPMENTAL STAGE; ERYTHROCYTE; MEROZOITE; NONHUMAN; PARASITE CULTIVATION; PARASITE DEVELOPMENT; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL;

CULTURE MEDIA, SERUM-FREE; ERYTHROCYTES; FATTY ACIDS, NONESTERIFIED; FLOW CYTOMETRY; HUMANS; PHOSPHOLIPIDS; PLASMODIUM FALCIPARUM;

BOVINAE; PLASMODIUM FALCIPARUM;

EID: 79951722526     PISSN: 00144894     EISSN: 10902449     Source Type: Journal    
DOI: 10.1016/j.exppara.2010.11.001     Document Type: Article

References (34)

1. Asahi H. Plasmodium falciparum: chemically defined medium for continuous intraerythrocytic growth using lipids and recombinant albumin. Experimental Parasitology 2009, 121:22-28.
2. Asahi H., Kanazawa T. Continuous cultivation of intraerythrocytic Plasmodium falciparum in a serum-free medium with the use of a growth-promoting factor. Parasitology 1994, 109:397-401.
3. Asahi H., Kanazawa T., Hirayama N., Kajihara Y. Investigating serum factors promoting erythrocytic growth of Plasmodium falciparum. Experimental Parasitology 2005, 109:7-15.
4. Asahi H., Kanazawa T., Kajihara Y., Takahashi K., Takahashi T. Hypoxanthine: a low molecular weight factor essential for growth of erythrocytic Plasmodium falciparum in a serum-free medium. Parasitology 1996, 113(Pt 1):19-23.
5. Bannister L.H., Hopkins J.M., Fowler R.E., Krishna S., Mitchell G.H. A brief illustrated guide to the ultrastructure of Plasmodium falciparum asexual blood stages. Parasitology Today 2000, 16:427-433.
6. Deponte M., Becker K. Plasmodium falciparum - do killers commit suicide?. Trends in Parasitology 2004, 20:165-169.
7. Diaz-Guerra M.J., Junco M., Bosca L. Oleic acid promotes changes in the subcellular distribution of protein kinase C in isolated hepatocytes. The Journal of Biological Chemistry 1991, 266:23568-23576.
8. Grellier P., Rigomier D., Clavey V., Fruchart J.C., Schrevel J. Lipid traffic between high density lipoproteins and Plasmodium falciparum-infected red blood cells. The Journal of Cell Biology 1991, 112:267-277.
9. Haldar K. Lipid transport in Plasmodium. Infectious Agents and Disease 1992, 1:254-262.
10. Haldar K., de Amorim A.F., Cross G.A. Transport of fluorescent phospholipid analogues from the erythrocyte membrane to the parasite in Plasmodium falciparum-infected cells. The Journal of Cell Biology 1989, 108:2183-2192.
11. Hardy S., Langelier Y., Prentki M. Oleate activates phosphatidylinositol 3-kinase and promotes proliferation and reduces apoptosis of MDA-MB-231 breast cancer cells, whereas palmitate has opposite effects. Cancer Research 2000, 60:6353-6358.
12. Hardy S., St-Onge G.G., Joly E., Langelier Y., Prentki M. Oleate promotes the proliferation of breast cancer cells via the G protein-coupled receptor GPR40. The Journal of Biological Chemistry 2005, 280:13285-13291.
13. Holz G.G. Lipids and the malarial parasite. Bulletin of the World Health Organization 1977, 55:237-248.
14. Izumiyama S., Omura M., Takasaki T., Ohmae H., Asahi H. Plasmodium falciparum: development and validation of a measure of intraerythrocytic growth using SYBR Green I in a flow cytometer. Experimental Parasitology 2009, 121:144-150.
15. Jensen J.B. Some aspects of serum requirements for continuous cultivation of Plasmodium falciparum. Bulletin of the World Health Organization 1979, 57(Suppl. 1):27-31.
16. Krishnegowda G., Gowda D.C. Intraerythrocytic Plasmodium falciparum incorporates extraneous fatty acids to its lipids without any structural modification. Molecular Biochemical Parasitology 2003, 132:55-58.
17. Leroy C., Tricot S., Lacour B., Grynberg A. Protective effect of eicosapentaenoic acid on palmitate-induced apoptosis in neonatal cardiomyocytes. Biochimica et Biophysica Acta 2008, 1781:685-693.
18. Maguire P.A., Sherman I.W. Phospholipid composition, cholesterol content and cholesterol exchange in Plasmodium falciparum-infected red cells. Molecular Biochemical Parasitology 1990, 38:105-112.
19. Malhi H., Bronk S.F., Werneburg N.W., Gores G.J. Free fatty acids induce JNK-dependent hepatocyte lipoapoptosis. The Journal of Biological Chemistry 2006, 281:12093-12101.
20. Mi-Ichi F., Kita K., Mitamura T. Intraerythrocytic Plasmodium falciparum utilize a broad range of serum-derived fatty acids with limited modification for their growth. Parasitology 2006, 133:399-410.
21. Mi-Ichi F., Kano S., Mitamura T. Oleic acid is indispensable for intraerythrocytic proliferation of Plasmodium falciparum. Parasitology 2007, 134:1671-1677.
22. Miller T.A., LeBrasseur N.K., Cote G.M., Trucillo M.P., Pimentel D.R., Ido Y., Ruderman N.B., Sawyer D.B. Oleate prevents palmitate-induced cytotoxic stress in cardiac myocytes. Biochemical and Biophysical Research Communications 2005, 336:309-315.
23. Mitamura T., Hanada K., Ko-Mitamura E.P., Nishijima M., Horii T. Serum factors governing intraerythrocytic development and cell cycle progression of Plasmodium falciparum. Parasitology International 2000, 49:219-229.
24. Moll G.N., Vial H.J., Ancelin M.L., Op den Kamp J.A., Roelofsen B., van Deenen L.L. Phospholipid uptake by Plasmodium knowlesi infected erythrocytes. FEBS Letters 1988, 232:341-346.
25. Murakami K., Chan S.Y., Routtenberg A. Protein kinase C activation by cis-fatty acid in the absence of Ca2+ and phospholipids. The Journal of Biological Chemistry 1986, 261:15424-15429.
26. Ridley R.G. Medical need, scientific opportunity and the drive for antimalarial drugs. Nature 2002, 415:686-693.
27. Simoes A.P., Moll G.N., Slotboom A.J., Roelofsen B., Op den Kamp J.A.F. Selective internalization of choline-phospholipids in Plasmodium falciparum parasitized human erythrocytes. Biochimica et Biophysica Acta 1991, 1063:45-50.
28. Simoes A.P., Roelofsen B., Op den Kamp J.A.F. Lipid compartmentalization in erythrocytes parasitized by Plasmodium spp. Parasitology Today 1992, 8:18-20.
29. Snow R.W., Guerra C.A., Noor A.M., Myint H.Y., Hay S.I. The global distribution of clinical episodes of Plasmodium falciparum malaria. Nature 2005, 434:214-217.
30. Surolia N., Surolia A. Triclosan offers protection against blood stages of malaria by inhibiting enoyl-ACP reductase of Plasmodium falciparum. Nature Medicine 2001, 7:167-173.
31. Vial H.J., Ancelin M.L. Malarial lipids. Malaria: Parasite Biology, Pathogenesis, and Protection 1998, 159-175. AMS Press, Washington, DC, USA. I.W. Sherman (Ed.).
32. Waller R.F., Ralph S.A., Reed M.B., Su V., Douglas J.D., Minnikin D.E., Cowman A.F., Besra G.S., McFadden G.I. A type II pathway for fatty acid biosynthesis presents drug targets in Plasmodium falciparum. Antimicrobial Agents and Chemotherapy 2003, 47:297-301.
33. Willet G.P., Canfield C.J. Plasmodium falciparum: continuous cultivation of erythrocyte stages in plasma-free culture medium. Experimental Parasitology 1984, 57:76-80.
34. Yeh I., Altman R.B. Drug Targets for Plasmodium falciparum: a post-genomic review/survey. Mini-Reviews in Medicinal Chemistry 2006, 6:177-202.